B-RAF and K-RAS mutations in prostatic adenocarcinoma

被引：0
|
作者：
Cho, NY
Kim, BH
Cho, YM
Moon, KC
Kang, GH
机构：
[1] Seoul Natl Univ, Seoul, South Korea
[2] Asan Med Ctr, Seoul, South Korea
来源：
MODERN PATHOLOGY | 2006年 / 19卷
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
607
引用
收藏
页码：133A / 133A
页数：1
相关论文
共 50 条
  • [21] K-Ras, H-Ras, N-Ras and B-Raf mutation and expression analysis in Wilms tumors: association with tumor growth
    Dalpa, Efterpi
    Gourvas, Victor
    Soulitzis, Nikolaos
    Spandidos, Demetrios A.
    MEDICAL ONCOLOGY, 2017, 34 (01)
  • [22] Detection of B-RAF and N-RAS mutations in human melanoma
    Goydos, JS
    Mann, B
    Kim, HJ
    Gabriel, EM
    Alsina, J
    Germino, FJ
    Shih, W
    Gorski, DH
    JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2005, 200 (03) : 362 - 370
  • [23] K-Ras, H-Ras, N-Ras and B-Raf mutation and expression analysis in Wilms tumors: association with tumor growth
    Efterpi Dalpa
    Victor Gourvas
    Nikolaos Soulitzis
    Demetrios A. Spandidos
    Medical Oncology, 2017, 34
  • [24] A Phase IB study of RAF dimer inhibitor BGB-283 in patients with B-RAF or K-RAS/N-RAS mutated solid tumors
    Desai, Jayesh
    Gan, Hui
    Barrow, Catherine
    Jameson, Michael B.
    Solomon, Ben
    Atkinson, Victoria
    Haydon, Andrew
    Millward, Michael
    Begbie, Stephen
    Brown, Michael
    Markman, Benjamin
    Patterson, William
    Hill, Andrew
    Horvath, Lisa
    Nagrial, Adnan
    Richardson, Gary
    Jackson, Christopher
    Friedlander, Michael
    Gibbs, David
    Parente, Phillip
    Yang, Jason
    Wang, Lai
    Chen, Yunxin
    Luo, Lusong
    CANCER RESEARCH, 2017, 77
  • [25] K-ras and B-raf gene mutations are not associated with gastrin- and CCK2-receptor mRNA expression in human colorectal tumour tissues
    Monstein, HJ
    Fransén, K
    Dimberg, J
    Söderkvist, P
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2004, 34 (02) : 100 - 106
  • [26] K-RAS AND B-RAF MUTATION AND CETUXIMAB THERAPY IN ADVANCED COLORECTAL CANCER PATIENTS : A RETROSPECTIVE MONOISTITUTIONAL STUDY.
    Frisinghelli, M.
    Soini, B.
    Ambrosini, G.
    Caffo, O.
    Caldara, A.
    Girlando, S.
    Barbareschi, M.
    Cuorvo, L., V
    Dalla Palma, P.
    Galligioni, E.
    ANNALS OF ONCOLOGY, 2009, 20
  • [27] INCREASED PREVALENCE OF K-RAS ONCOGENE MUTATIONS IN LUNG ADENOCARCINOMA
    MILLS, NE
    FISHMAN, CL
    ROM, WN
    DUBIN, N
    JACOBSON, DR
    CANCER RESEARCH, 1995, 55 (07) : 1444 - 1447
  • [28] c-Raf, but Not B-Raf, Is Essential for Development of K-Ras Oncogene-Driven Non-Small Cell Lung Carcinoma
    Blasco, Rafael B.
    Francoz, Sarah
    Santamaria, David
    Canamero, Marta
    Dubus, Pierre
    Charron, Jean
    Baccarini, Manuela
    Barbacid, Mariano
    CANCER CELL, 2011, 19 (05) : 652 - 663
  • [29] CPG ISLAND METHYLATION IN MGMT, CADHERIN E AND H PROMOTERS, K-RAS AND B-RAF MUTATIONS: DETERMINING PROGRESSION AND SEQUENCE IN COLORECTAL ADENOMA-CARCINOMA
    Metzger, B.
    Wenner, T.
    Mahon, G.
    Dicato, M.
    ANNALS OF ONCOLOGY, 2010, 21 : 208 - 208
  • [30] K-RAS GTPase- and B-RAF kinase-mediated T-cell tolerance defects in rheumatoid arthritis
    Singh, Karnail
    Deshpande, Pratima
    Li, Guangjin
    Yu, Mingcan
    Pryshchep, Sergey
    Cavanagh, Mary
    Weyand, Cornelia M.
    Goronzy, Joerg J.
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2012, 109 (25) : E1629 - E1637
12345